Health
Will the market for **CRISPR-based diagnostics** (disease detection) surpass the market for CRISPR-based therapeutics (treatment) by 2026?
Forecasting the greater immediate commercial success of gene-editing technology in diagnosis over therapy.
Yes 0%Maybe 80%No 20%
5 total votes